The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.

In a recent webinar, Dr. Lena Smirnova explained how brain microphysiological systems are transforming in vitro neurotoxicity testing and disease modeling. NewsMedical compiled the key highlights in ...

A new consensus by a team of experts in China has been established to guide researchers in evaluating the percutaneous absorption of cosmetic functional ingredients using in vitro diffusion cell ...

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...

For decades, animal models have been the gold standard for preclinical testing of potential drugs. Yet, even the best animal models are not perfect. For example, small rodent species with engrafted ...

Common Mistakes to Avoid in Order to Improve Translation of Interaction Data to the Clinic Since 2006, when the U.S. FDA published a draft guidance on drug interaction studies, it has expected new ...